{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:51:15Z","timestamp":1793663475934,"version":"4.5.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101164772 - D- MAP"],"award-info":[{"award-number":["101164772 - D- MAP"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["SSMF CG -24-0191-B-H-01"],"award-info":[{"award-number":["SSMF CG -24-0191-B-H-01"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["CG-24-0191-B-H-01"],"award-info":[{"award-number":["CG-24-0191-B-H-01"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"SciLifeLab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","award":["KAW 2024 . 0108"],"award-info":[{"award-number":["KAW 2024 . 0108"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106359","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:27:19Z","timestamp":1782858439000},"page":"106359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The role of mucosal IgA in protection against influenza A H1N1 virus infection in a real-world setting"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-8258","authenticated-orcid":false,"given":"Oscar","family":"Bladh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8089-4352","authenticated-orcid":false,"given":"Tam\u00e1s","family":"Pongr\u00e1cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherina","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Berkell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Marking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Greilert Norin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rihani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J.","family":"Alm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"\u00c5berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1345-6491","authenticated-orcid":false,"given":"Charlotte","family":"Th\u00e5lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ebiom.2026.106359_bib1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/cid\/cit060","article-title":"Influenza vaccine effectiveness in the community and the household","volume":"56","author":"Ohmit","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106359_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41591-023-02219-5","article-title":"Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population","volume":"29","author":"Lau","year":"2023","journal-title":"Nat Med"},{"issue":"45","key":"10.1016\/j.ebiom.2026.106359_bib3","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1016\/j.vaccine.2021.08.010","article-title":"A Research and Development (R&D) roadmap for influenza vaccines: looking toward the future","volume":"39","author":"Moore","year":"2021","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106359_bib4","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/339710","article-title":"Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa","volume":"185","author":"Brokstad","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106359_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02372-23","article-title":"Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers","volume":"15","author":"Bean","year":"2024","journal-title":"mBio"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106359_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00102-7","article-title":"Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose","volume":"4","author":"Bladh","year":"2023","journal-title":"Lancet Microbe"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106359_bib7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMc2209651","article-title":"Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection","volume":"387","author":"Havervall","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106359_bib8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/s41467-023-36984-1","article-title":"Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers","volume":"14","author":"Marking","year":"2023","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106359_bib9","doi-asserted-by":"crossref","first-page":"e4375","DOI":"10.1093\/cid\/ciaa1781","article-title":"Real-time investigation of a large nosocomial influenza A outbreak informed by genomic epidemiology","volume":"73","author":"Javaid","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10127","key":"10.1016\/j.ebiom.2026.106359_bib10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"issue":"7942","key":"10.1016\/j.ebiom.2026.106359_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-022-05522-2","article-title":"The WHO estimates of excess mortality associated with the COVID-19 pandemic","volume":"613","author":"Msemburi","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106359_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106359_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2026.106359_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.957107","article-title":"Mucosal immunity: the missing link in comprehending SARS-CoV-2 infection and transmission","volume":"13","author":"Russell","year":"2022","journal-title":"Front Immunol"},{"issue":"577","key":"10.1016\/j.ebiom.2026.106359_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci Transl Med"},{"issue":"44","key":"10.1016\/j.ebiom.2026.106359_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107148118","article-title":"Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG","volume":"118","author":"Sun","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2026.106359_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2013.00222","article-title":"Secretory IgA: designed for anti-microbial defense","volume":"4","author":"Brandtzaeg","year":"2013","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106359_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ymthe.2024.01.025","article-title":"Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2","volume":"32","author":"G\u00f6ritzer","year":"2024","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106359_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2315354120","article-title":"Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of omicron lineages","volume":"121","author":"Marcotte","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106359_bib20","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-022-32389-8","article-title":"SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals","volume":"13","author":"Sano","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106359_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","article-title":"Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection","volume":"15","author":"Sheikh-Mohamed","year":"2022","journal-title":"Mucosal Immunol"},{"issue":"52","key":"10.1016\/j.ebiom.2026.106359_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106359_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1473-3099(22)00834-9","article-title":"7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection","volume":"23","author":"Marking","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106359_bib24","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJMc2310347","article-title":"Mucosal and serum antibodies 3 weeks after symptomatic BA.2.86 infection","volume":"389","author":"Bladh","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106359_bib25","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/S1473-3099(23)00421-8","article-title":"Mucosal IgA protects against BQ.1 and BQ.1.1 infection","volume":"23","author":"Marking","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106359_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104402","article-title":"SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination","volume":"87","author":"Liew","year":"2023","journal-title":"eBioMedicine"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106359_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jmv.1890170405","article-title":"Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine","volume":"17","author":"Johnson","year":"1985","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106359_bib28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106359_bib29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3389\/fmicb.2017.00900","article-title":"Nasal IgA provides protection against human influenza challenge in volunteers with low serum influenza antibody titre","volume":"8","author":"Gould","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2026.106359_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1346749","article-title":"Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum","volume":"15","author":"Bladh","year":"2024","journal-title":"Front Immunol"},{"issue":"48","key":"10.1016\/j.ebiom.2026.106359_bib32","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1016\/j.vaccine.2012.09.018","article-title":"The role of nasal IgA in children vaccinated with live attenuated influenza vaccine","volume":"30","author":"Ambrose","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106359_bib33","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1038\/s41467-023-43842-7","article-title":"Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine","volume":"14","author":"Thwaites","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106359_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jis641","article-title":"Localized mucosal response to intranasal live attenuated influenza vaccine in adults","volume":"207","author":"Barr\u00eda","year":"2013","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106359_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1750-2659.2011.00330.x","article-title":"Induction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults","volume":"6","author":"Fujimoto","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.ebiom.2026.106359_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105912","article-title":"Impact of systemic SARS-CoV-2 vaccination on mucosal IgA responses to subsequent breakthrough infection","volume":"120","author":"Marking","year":"2025","journal-title":"eBioMedicine"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106359_bib37","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1128\/JVI.00979-13","article-title":"Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs","volume":"87","author":"Seibert","year":"2013","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106359_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01421-21","article-title":"Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the guinea pig model","volume":"96","author":"Tan","year":"2022","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106359_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00560-19","article-title":"Mucosal immunity against neuraminidase prevents influenza B virus transmission in guinea pigs","volume":"10","author":"McMahon","year":"2019","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106359_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03243-19","article-title":"Influenza virus infection induces a narrow antibody response in children but a broad recall response in adults","volume":"11","author":"Meade","year":"2020","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106359_bib41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","article-title":"Novel correlates of protection against pandemic H1N1 influenza A virus infection","volume":"25","author":"Ng","year":"2019","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106359_bib42","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.hlife.2024.05.004","article-title":"Nasal mucosal secretory immunoglobulin A but not serum antibodies is resistant to omicron evasion","volume":"2","author":"Chen","year":"2024","journal-title":"hLife"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106359_bib43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-024-01906-0","article-title":"Intranasal adenovirus-vectored omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106359_bib45","first-page":"Cd004876","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"10287","key":"10.1016\/j.ebiom.2026.106359_bib46","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2026.106359_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103788","article-title":"Mucosal immune response in BNT162b2 COVID-19 vaccine recipients","volume":"75","author":"Azzi","year":"2022","journal-title":"eBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106359_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02280-23","article-title":"Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection","volume":"14","author":"Bhavsar","year":"2023","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106359_bib49","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2026.106359_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127356","article-title":"A review of currently licensed mucosal COVID-19 vaccines","volume":"61","author":"Tscherne","year":"2025","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106359_bib51","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/vaccines12070795","article-title":"SARS-CoV-2 vaccines: the advantage of mucosal vaccine delivery and local immunity","volume":"12","author":"Tobias","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106359_bib52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106359_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41541-023-00654-6","article-title":"Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities\u2014workshop report","volume":"8","author":"Knisely","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106359_bib54","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.vaccine.2009.12.058","article-title":"Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination","volume":"28","author":"Joo","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106359_bib55","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106359_bib56","volume":"13","author":"Xu","year":"2024","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106359_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41541-023-00717-8","article-title":"Phase III pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin\u00ae)","volume":"8","author":"Singh","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2026.106359_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126586","article-title":"A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge","volume":"45","author":"Slamanig","year":"2025","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106359_bib59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jviromet.2013.07.032","article-title":"Serum antibodies against native and denaturated hemagglutinin glycoproteins detected by ELISA as correlates of protection after influenza vaccination in healthy vaccinees and in kidney transplant recipients","volume":"193","author":"Grund","year":"2013","journal-title":"J Virol Methods"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:33:25Z","timestamp":1785972805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"alternative-id":["S2352396426002422"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106359","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of mucosal IgA in protection against influenza A H1N1 virus infection in a real-world setting","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106359"}}